Condition
Advanced Solid Tumors
Estimated Enrollment: 0
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 0C-08-2
Study First Received: November 4, 2009
Last Updated: May 19, 2014
Estimated Primary Completion Date: null
Primary Outcome Measures:
To determine the maximal tolerated dose (MTD) of Ixabepilone and Pemetrexed in advanced solid tumors.|Response Rate
Sponsors and Collaborators:
University of Southern California
Website Link: https://ClinicalTrials.gov/show/NCT01170871
